{"disease":{"id":"first-line-targeted-therapy-failure","name":"first line targeted therapy failure"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07537777","title":"Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":29,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}